Recent Developments in Disease Management ROI Measurement (2 Part Webcast)
Solucia Inc. invites you to attend a two-part webcast entitled: "Recent developments in DM ROI measurement". Speakers are consulting actuary Ian Duncan, FSA, MAAA (designated "the leading actuary in Disease Management"by Al Lewis of the Disease Management Purchasing Consortium), Andrea DeVries, Ph.D., Analyst, Highmark Inc. and Al Lewis, President of the Disease Management Purchasing Consortium.
Discussions of Disease Management ROI in the past have focused on how difficult it is to achieve credibility because of confounding factors such as regression to the mean. Purchasers were left with the impression that there was no way to produce believable savings estimates. Recent research, however, is beginning to shed some badly-needed light in this area. During the webcast we will discuss the practical application of some of the recent research and publications covering the impact on Disease Management ROI of factors such as bias and medical trend. The papers that will be covered include:
- "Estimating the Return on Investment in Disease Management Programs Using a Pre-Post Analysis"(by Fetterolf, Wennberg and DeVries, published in Disease Management, Fall 2004);
- "A Comparative Analysis of Chronic and Non-chronic Insured Member Cost Trends"(by Bachler, Duncan and Juster, published by the Society of Actuaries);
- "Testing Actuarial Methods for Evaluating Disease Management Savings" by Duncan, Owen and Dove (submitted to the Society of Actuaries 2005).
- The principal issues identified in the Disease Management Purchasing Consortium (DPMC) "White Paper"by Lewis, Linden and Duncan (unpublished).
Registrants will be provided with copies of the Society of Actuaries and DMAA papers in advance. Registrants may also purchase a copy of the DMPC White Paper at the discounted price of $300. Write to info@soluciaconsulting.com for information on ordering with the discount.
Purchase the Conference CD ROM
What You'll Learn:
Part I (October 6): Andrea DeVries, Ph.D. and Ian Duncan
Andrea DeVries will discuss the Population Evaluation method (adjusted historical cost)
- Implementation and calculation
- Potential Biases
- Factors to control for (use of the check-list)
- The standard DM evaluation method (adjusted historical control) relies heavily on cost-trends for its results.
Ian Duncan will discuss the recent Society of Actuaries study of medical cost trends:
- The meaning and calculation of cost-trends;
- The concept of migration bias in DM Measurement;
- Results of the SOA trend study.
Part II (October 13): Al Lewis and Ian Duncan
Al Lewis will summarize the key the recommendations of the Disease Management Purchasing Consortium White Paper.
- Key findings on avoiding bias in study design;
- Plausibility metrics and measures.
Ian Duncan will discuss the results of the test of the Adjusted Historical Control methodology assumptions in a chronic population at Highmark.
- Chronic identification;
- Trend (retrospective identification);
- Continuous eligibility.
The Details
Original Webinars: Thursday October 6, 2005 (Part I) and Thursday October 13, 2005 (Part II)
CD-ROM: $150 for non-attendees (buy now)
DMPC White Paper: $1,000.00, discounted to $300 for webcast registrants. Contact info@soluciaconsulting.com for discount information.(Click here to purchase)
Our Speakers
Ian Duncan, FSA MAAA, President, Solucia Inc.
Ian Duncan has thirty years of experience in the healthcare actuarial field. He led the Health Underwriting practice at PricewaterhouseCoopers Management Consulting, and between 2000 and 2002 was General Manager of a start-up provider of predictive modeling and other services to the Disease Management industry. Clients included United Healthcare, HealthNet of Arizona, Lifeguard and M-Plan. Currently he consults to vendors and purchasers of DM services, health plans, predictive modeling companies and reinsurers who are seeking a financial return for their Medical Management programs.
Alfred Lewis, President of the Disease Management Purchasing Consortium International, Inc.
Al Lewis is the founder and President of the Disease Management Purchasing Consortium International, Inc. DMPC is the leading consultant/procurement broker in the field of disease management. The Consortium membership includes 78 health plans, 12 employers, 12 states and 2 countries. DMPC offers the field’s only certification for savings measurement methodology. Lewis has twice won the highest individual award from the Disease Management Association of America, which he also founded, and in December 2004, he was named the most influential person in disease management by Managed Healthcare Executive, a distinction also granted by Disease Management News.
Andrea DeVries, PhD, Highmark, Inc.
Dr. DeVries has been part of the Informatics Department at Highmark since 1999. During her time at Highmark she has managed a team performing ROI calculations for disease management and other medical management initiatives. In 2003 she created an area for health services research involving academic, federal, and private sector research and analytic partners. She completed a Doctoral program in Health Services Research, Policy, and Administration at the University of Minnesota in 2001. Her dissertation "Affecting Physician Prescribing Behavior: Factors Influencing the Success of a Managed Care Intervention"evaluates a health plan initiative to control pharmacy utilization. Before coming to Highmark Blue Cross Blue Shield she worked as an analyst at Prime Therapeutics, Inc., (a jointly owned subsidiary of Blue Cross Blue Shield of Minnesota and Blue Cross Blue Shield of Nebraska).
